Provided by Tiger Trade Technology Pte. Ltd.

Arrowhead Pharmaceuticals

64.52
-0.1200-0.19%
Post-market: 64.950.4300+0.67%19:23 EST
Volume:24.09M
Turnover:1.56B
Market Cap:9.03B
PE:-5.29K
High:68.44
Open:65.50
Low:63.46
Close:64.64
52wk High:76.76
52wk Low:9.57
Shares:140.01M
Float Shares:120.00M
Volume Ratio:8.79
T/O Rate:20.08%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.0122
EPS(LYR):-0.0122
ROE:75.50%
ROA:14.35%
PB:15.89
PE(LYR):-5,291.56

Loading ...

Arrowhead price target lowered to $78 from $81 at Morgan Stanley

TIPRANKS
·
Yesterday

Analysts Offer Insights on Healthcare Companies: Arrowhead Pharmaceuticals (ARWR), Resmed (RMD) and Bristol-Myers Squibb (BMY)

TIPRANKS
·
Yesterday

U.S. RESEARCH ROUNDUP-Amazon, Estée Lauder, Ralph Lauren

Reuters
·
Yesterday

Arrowhead   Pharmaceuticals  misses Q1 revenue estimates

Reuters
·
Yesterday

Stock Track | Arrowhead Pharmaceuticals Plummets 5.88% Intraday After Missing Q1 Revenue Estimates

Stock Track
·
Yesterday

Arrowhead steigert Umsatz im ersten Quartal 2026 auf 264,03 Mio. USD um mehr als das 100-Fache

Reuters
·
Yesterday

BRIEF-Arrowhead Pharmaceuticals Q1 EPS USD 0.22

Reuters
·
Yesterday

Arrowhead Pharmaceuticals Reports Fiscal 2026 First Quarter Results

THOMSON REUTERS
·
Yesterday

BUZZ-ADT rises ahead of S&P SmallCap addition

Reuters
·
Feb 05

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Feb 05

Ciena Set to Join S&P500

MT Newswires Live
·
Feb 05

Arrowhead to replace Ciena in S&P 400 at open on 2/9

TIPRANKS
·
Feb 05

Earning Preview: Arrowhead Pharmaceuticals — revenue is expected to increase, and institutional views tilt positive

Earnings Agent
·
Jan 29

BUZZ-Arrowhead rises as it begins trial of high-cholesterol disorder drug

Reuters
·
Jan 27

Arrowhead Pharmaceuticals Doses First Subject in Clinical Trial of Treatment for Mixed Hyperlipidemia

MT Newswires Live
·
Jan 27

Arrowhead Pharmaceuticals Initiates Phase 1/2a Study of Aro-Dimer-Pa – the First Dual Functional Rnai Therapeutic for the Treatment of Mixed Hyperlipidemia

THOMSON REUTERS
·
Jan 27

Arrowhead Pharmaceuticals Inc. Announces Date for Upcoming Annual Stockholders Meeting

Reuters
·
Jan 27

Arrowhead Pharmaceuticals (ARWR) Is Up 5.0% After China Approves Redemplo Commercialisation With Sanofi

Simply Wall St.
·
Jan 25

B. Riley Raises Price Target on Arrowhead Pharmaceuticals to $101 From $61, Keeps Buy Rating

MT Newswires Live
·
Jan 22

Analysts Offer Insights on Healthcare Companies: Belite Bio, Inc. ADR (BLTE), Arrowhead Pharmaceuticals (ARWR) and Alector (ALEC)

TIPRANKS
·
Jan 21